Access cutting-edge primary open angle glaucoma (poag) treatment through this phase 1/2 clinical trial at a research site in Deerfield Beach. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Deerfield Beach location
Preparing your pre-screening questions…
Access primary open angle glaucoma (poag) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related primary open angle glaucoma (poag) treatment provided free
Check if you qualify for this primary open angle glaucoma (poag) clinical trial in Deerfield Beach, FL
No-Cost Study Care
Local to Deerfield Beach
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study will test an experimental drug called REGN22530 ("study drug") to see if it can help treat people with primary open angle glaucoma or ocular hypertension. REGN22530 is an experimental drug that is designed to bind with a protein in the eye that has been shown to cause a buildup of fluid inside the eye and cause increased Intraocular Pressure (IOP). REGN22530 attaches to this protein and stops it from working which may allow more fluid to drain out of the eye and decrease the pressure. The study is looking at: * What side effects REGN22530 might cause * How much REGN22530 is in the blood and eye fluid at different times * If the body has any reactions to REGN22530 (which may cause REGN22530 to not work as well) * How the body and eye pressure respond after having REGN22530, which can help researchers understand why REGN22530 works better in some people than others * How well REGN22530 works
Sponsor: Regeneron Pharmaceuticals
Yes, this clinical trial (NCT07675824) has an active research site in Deerfield Beach, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for primary open angle glaucoma (poag) treatment options in Deerfield Beach, FL, this clinical trial (NCT07675824) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Deerfield Beach research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced primary open angle glaucoma (poag) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all primary open angle glaucoma (poag) clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Deerfield Beach — not just this study.
Browse Pulmonary Embolism Trials in Deerfield Beach →